FDC
|
The Current P/S Ratio of FDC is 2.79.
| Share Price | ₹356.1 | Apr 16,2026 |
| Market Cap | ₹5,796.5 Cr | |
| Sales-TTM | ₹2,078.0 Cr | TTM-Consolidated Results |
| Price/Sales | 2.79x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of FDC
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹5,796.5 Cr] as on Apr 16,2026
(/) Sales [ ₹2,078.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.79x ]
Thus, for FDC , the investors are currently willing to pay '2.79 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of FDC !
The chart below summarizes the trend in P/S Ratio of FDC over the last five years.
Historical PS (Price/Sales) ratio chart of FDC
PS Ratio Performance Analysis for FDC
- FDC 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.09x.
- FDC 's operated at median p/e ratio of 3.05x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, FDC 's p/e ratio peaked in Mar2021 at 3.62x.
- FDC 's p/e ratio hit its five-year low in Mar2023 of 2.39x.
How does FDC 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| FDC | 2,078.0 | 2.79 | 5,796.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.15 | 406,243.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 16.21 | 167,179.0 |
| CIPLA LTD | 28,351.1 | 3.51 | 99,417.9 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.04 | 140,670.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.94 | 101,932.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.24 | 86,888.0 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.62 | 94,505.5 |
| LUPIN LTD | 26,150.5 | 4.07 | 106,363.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.43 | 80,504.9 |
| ABBOTT INDIA LTD | 6,824.1 | 8.05 | 54,955.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs FDC 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.43x |
| Max industry PS | 16.21x |
| Median industry PS | 4.07x |
| Average industry PS | 6.19x |
You may also like the below Video Courses